Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

Also called NCT03164785

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 202 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03164785
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03164785. Randomized; no masking; primary purpose treatment. Start 2017-07-24 (actual); primary completion 2020-09-26 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease
Condition
Type 2 Diabetes Mellitus
Condition
Diabetic Kidney Disease
Intervention (Drug)
Jinshuibao Capsule
Lead sponsor
Second Xiangya Hospital of Central South University (class: other)

Record details

Record id
cardio:ct-nct03164785
Content hash
7c0d243d647cb83efc8bc76e592e9d08e0ea80e1459baf6f35879e02a70c2411